CD8A and neoplasm: To support clinical translation, future work must establish tumor-type-specific Ttex/CD8+ ratio thresholds, validate digital pathology and AI-assisted pipelines across platforms, and develop harmonized, open-access benchmark datasets that ensure algorithmic reproducibility and regulatory readiness (239).